JK

Jay Kumar Saraf

Active Director Director DIN 00017232
DIN 00017232 First appointment Oct 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2004
Shareholding value •••• Premium profile

About Jay Kumar Saraf

Data last updated:

Jay Kumar Saraf is a Director at Wilcure Remedies Private Limited (since 2004). The company operates in Pharma. Wilcure Remedies Private Limited reported revenue of ₹23.04 Cr (FY 2025).

DIN 00017232
Primary Designation Director
Industry Pharma
First Appointment 08 Oct 2004
Oldest Company Age 22 yrs
Largest company Wilcure Remedies Private Limited · ₹23.04 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wilcure Remedies Private Limited U24232MP2004PTC017022
Director08 Oct 20042004₹23.04 Cr (FY 2025)Active

Board colleagues of Jay Kumar Saraf

Directorship timeline

Open interactive timeline →
Wilcure Remedies Private Limited
Premium access

Shareholding and investment profile for Jay Kumar Saraf

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jay Kumar Saraf

Jay Kumar Saraf currently holds 1 directorship: Wilcure Remedies Private Limited (Director, since 08 Oct 2004, revenue ₹23.04 Cr (FY 2025)).

Jay Kumar Saraf was first appointed on 08 Oct 2004 as Director at Wilcure Remedies Private Limited.

The current boards of Jay Kumar Saraf's companies include Devendra Saraf (Wilcure Remedies Private Limited), Shailendra Saraf (Wilcure Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available